Yield10 Bioscience Inc expected to post a loss of 30 cents a share - Earnings Preview

Yield10 Bioscience

29/03/2024 20:18

* Yield10 Bioscience Inc  YTEN.OQ   YTEN.O  is expected
to show a
fall in quarterly revenue when it reports  results on April 1
for the period ending December 31 2023
    * 
    * ​LSEG's mean analyst estimate for Yield10 Bioscience Inc
is for
a loss of 30 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $0.50​, above​ its last closing price
of $0.38. ​​​

This summary was machine generated March 29 at 20:18 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)